People

Kathryn Mills, MD

Resilience in the Face of Pandemic: The Impact of COVID-19 on the Psychologic Morbidity and Health-Related Quality of Life Among Women With Ovarian Cancer.
Javellana M, Hlubocky FJ, Somasegar S, Sorkin M, Kurnit KC, Jani I, Stock E, Mills K, Lengyel E, Lee NK. Resilience in the Face of Pandemic: The Impact of COVID-19 on the Psychologic Morbidity and Health-Related Quality of Life Among Women With Ovarian Cancer. JCO Oncol Pract. 2022 Feb 24; OP2100514.
PMID: 35201895

Tumor board presentation of a woman with metastatic, hormone receptor-positive, mismatch repair-deficient endometrial cancer.
Bennett JA, Fleming GF, Kurnit KC, Mills KA, vanWeelden WJ. Tumor board presentation of a woman with metastatic, hormone receptor-positive, mismatch repair-deficient endometrial cancer. CA Cancer J Clin. 2022 Mar; 72(2):102-111.
PMID: 35077576

Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers?
Mills KA, Joshi TV, West L, Kuznicki M, Kent L, Hokenstad AN, Cripe JC, Woolfolk C, Senter L, Bakkum-Gamez JN, Wenham RM, Cohn DE, Bae-Jump V, Thaker PH. Is hormonal therapy after risk-reducing salpingo-oophorectomy associated with an increased risk of malignancy in pathogenic variant carriers? Gynecol Oncol. 2020 06; 157(3):706-710.
PMID: 32143914

Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab.
Gillen J, Mills KA, Dvorak J, Zheng B, Thai T, Salani R, Cosgrove CM, Davidson B, Thaker PH, Moore KN. Imaging biomarkers of adiposity and sarcopenia as potential predictors for overall survival among patients with endometrial cancer treated with bevacizumab. Gynecol Oncol Rep. 2019 Nov; 30:100502.
PMID: 31720357

Reply to: Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter.
Grozio A, Mills K, Yoshino J, Bruzzone S, Sociali G, Tokizane K, Lei HC, Sasaki Y, Migaud M, Imai SI. Reply to: Absence of evidence that Slc12a8 encodes a nicotinamide mononucleotide transporter. Nat Metab. 2019 07; 1(7):662-665.
PMID: 32694650

Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next?
Mills KA, Lopez H, Sun L, Cripe JC, Litz T, Thaker PH, Powell MA, Mutch DG, Fuh KC. Type II endometrial cancers with minimal, non-invasive residual disease on final pathology: What should we do next? Gynecol Oncol Rep. 2019 Aug; 29:20-24.
PMID: 31193699

Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy?
Liang B, Lange SS, Massad LS, Dick R, Mills KA, Hagemann AR, McCourt CK, Thaker PH, Fuh KC, Mutch DG, Powell MA, Kuroki LM. Do gynecologic oncology patients with severely diminished renal function and urinary tract obstruction benefit from ureteral stenting or percutaneous nephrostomy? Gynecol Oncol Rep. 2019 May; 28:136-140.
PMID: 31061871

p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts.
Mills KA, Quinn JM, Roach ST, Palisoul M, Nguyen M, Noia H, Guo L, Fazal J, Mutch DG, Wickline SA, Pan H, Fuh KC. p5RHH nanoparticle-mediated delivery of AXL siRNA inhibits metastasis of ovarian and uterine cancer cells in mouse xenografts. Sci Rep. 2019 03 18; 9(1):4762.
PMID: 30886159

Association between body mass index and surgical menopausal symptoms in patients with early stage endometrial cancer.
Cripe JC, Buchanan TR, Kuroki LM, Wan L, Mills KA, Massad L, Hagemann AR, Fuh KC, Mutch DG, Powell MA, Matsuo K, Thaker PH. Association between body mass index and surgical menopausal symptoms in patients with early stage endometrial cancer. Gynecol Oncol. 2019 04; 153(1):123-126.
PMID: 30651188

SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth.
Mills KA, Roach ST, Quinn JM, Guo L, Beck HM, Lomonosova E, Ilivicky AR, Starks CM, Lawrence JA, Hagemann AR, McCourt C, Thaker PH, Powell MA, Mutch DG, Fuh KC. SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth. Gynecol Oncol. 2018 11; 151(2):337-344.
PMID: 30190114

View All Publications